The last PD1-VAXX trial saw a grade 5 toxicity (the treatment killed a patient) and was terminated early (recruiting roughly 25% of the planned patient population) with no update provided to shareholders.
That's what I'd call a shelved trial?
Ann: 1st Australian site activated PD1-Vaxx Neo-POLEM Ph II trial, page-7
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
42.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $93.34M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | 45.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.0¢ | 1177 | 1 |
View Market Depth
| Last trade - 16.21pm 14/07/2025 (20 minute delay) ? |
| IMU (ASX) Chart |
Day chart unavailable